280
Participants
Start Date
December 31, 2008
Primary Completion Date
November 30, 2011
Study Completion Date
May 31, 2012
Lopinavir/Ritonavir (200/50 mg) Tablets + Zidovudine + 3TC
Zidovudine 300mg PO BID + 3TC 150 mg PO BID + Lopinavir/Ritonavir (200/50 mg) two tablets PO BID
Chelstone Clinic, Lusaka
Collaborators (1)
University of Toronto
OTHER
Abbott
INDUSTRY
University of Zambia
OTHER